Current Issue: 2023,Vol.31,NO.04 36
[591-597] Influence of Phe112,Trp86 and Tyr108 on binding and chemotaxis effects of CCR5 to chemokine CCL5
[SONG Xiaoxu,CHEN Ling,YU Jing]
2023 04 [Abstract]()
[597-602] lncRNA MEG3 regulates the NLRP3/caspase-1/GSDMD pathway to affect the sensitivity of triple-negative breast cancer to paclitaxel
[YU Bing1 ,YANG Xu2 ,CHEN Zhimeng2 ,LEI Meng2]
2023 04 [Abstract]()
[603-609] Lycorine inhibits the proliferation of esophageal cancer cells through regulating G3BP1/TGF-β/Smad signaling pathway
[REN Liping1,2 ,JIN Shaoju1,2 ,MA Yongchao2 ,XU Songtao2,3]
2023 04 [Abstract]()
[609-617] Integrated analysis of gastric cancer pharmacogenomic profiles
[HAI Yanru,CAO Lihua,YU Huan,WU Jianmin]
2023 04 [Abstract]()
[618-625] Study on the effects of biological function and sensitivity to radiotherapy and chemotherapy of lupeol on nasopharyngeal carcinoma cells and its mechanism of apoptosis
[WANG Ansheng1,2 ,LI Yuanquan1 ,FENG Yiyuan1 ,YANG Jing2 ，WU Chuncheng2 ,DENG Shishan2,3 ,YANG Hongbin1]
2023 04 [Abstract]()
[625-631] Salidroside suppresses proliferation and migration of non-small cell lung cancer cells via miRNA-210-3p/E2F3
[YANG Qi1,2 ,MING Yujun1,2 ,WANG Xiujuan1,2 ,JIANG Li2 ，CHEN Shaoping2]
2023 04 [Abstract]()
[632-637] Cinobufotalin-mediated miR-497-5p/VEGFA pathway regulates proliferation,apoptosis and angiogenesis of lung cancer cells
[CAI Yuliang1 ,ZHENG Jie2 ,ZHANG Jinhua1 ,PENG Haiping1 ,YANG Binfeng1 ,HUANG Bangrong1]
2023 04 [Abstract]()
[638-643] Siglec-15×CD3 bispecific antibody inhibits the growth of colorectal cancer cells by mediating T cell antitumor immunity
[WU Yuanhao1 ,HUANG Ping1 ,LI Laichun2]
2023 04 [Abstract]()
[643-647] Application value of multidisciplinary team pattern in diagnosis and treatment for glioblastoma multiforme
[SHI Ji1,2,ZHANG Ye2,SUN Peixin2,YAO Bing2,HAO Yuanyuan2,PIAO Haozhe2]
2023 04 [Abstract]()
[648-652] Expression and clinical significance of ITGA5 in glioma tissues
[MENG Xianglong1,2,ZHANG Moxuan3,WANG Mingguang2,SUN Qiang1,XUE Zhengchun1,DU Fei1,FU Jidi4]
2023 04 [Abstract]()
[653-658] A pilot study on the difference of gut microbiota between patients with lung cancer and healthy controls
[JIAO Qianqian1，YAN Junhong2，WANG Jing1，ZHU Jiwei1，PAN Lei1]
2023 04 [Abstract]()
[659-663] Thoracic parameter analysis for optimizing the magnetic anchoring device used to pull the esophagus in thoracoscopic esophagectomy
[CHEN Wenwen1,2,WU Jiayi2,CHENG Yuan2,ZHAO Yixin2,SONG Yali1,LYU Yi3,4,FU Junke1,ZHANG Yong1,4]
2023 04 [Abstract]()
[663-669] Establishment and evaluation of EGFR mutation prediction model based on serum tumor markers and medical imaging in patients with lung adenocarcinoma
[WANG Qiutong1,WU Shuang1,WANG Ming2,CHEN Ling1,AN Yuezhen2,JIANG Junjie2,WANG Hansen3,ZHAO Rui4]
2023 04 [Abstract]()
[669-674] Analysis of molecular subtypes，treatment and outcomes in advanced non-small cell lung cancer patients with KRAS mutation
[WANG Diming1,YE Wei2,SHI Qingming1]
2023 04 [Abstract]()
[675-680] Comparative analysis of clinicopathological features of bronchiolar adenoma with proximal type and distal type (4 cases)
[YANG Chunmei,DENG Wei]
2023 04 [Abstract]()
[681-686] Comparison of effect of Lap-ISR and Lap-ISR with trans-anal pull-in telescopic anastomosis in anus-preserving operation for low rectal cancer
[ZHAO Lihua1,HUANG Qianpeng2,CHU Zhaozhen2,FU Zexian3,LI Lei2]
2023 04 [Abstract]()
[686-689] Clinical efficacy analysis of laparoscopic-assisted transanal total mesorectal excision in the treatment of rectal cancer
[LU Chen,LIANG Daoming,XIANG Qianming,XIA Chuqi,LUO Haibo,YANG Yanlong]
2023 04 [Abstract]()
[690-693] Risk factor of parastomal hernia after abdominoperineal excision for rectal cancer
[SHEN Jian,LI Minzhe]
2023 04 [Abstract]()
[693-697] The expression and clinical significance of BCAP31 in colorectal cancer tissues
[WANG Qi1,2,LEI Wenqi2,CHENG Lin2,HAN Bin3,LI Zhigui4,WANG Xiaodong4,ZHOU Chunyang1,ZHOU Liming2]
2023 04 [Abstract]()
[698-701] The expressions and clinical significance of E-cadherin in gastric adenocarcinoma
[GUO Xiaoxiong,ZHONG Canmei,CHEN Fenglin]
2023 04 [Abstract]()
[702-706] Clinical features of children with primary malignant non-Wilms renal tumors
[JIAO Yangyang,FU Pan,YANG Jingwei,JIANG Shayi,LIAO Xuelian,SHAO Jingbo]
2023 04 [Abstract]()
[707-711] Preoperative albumin to globulin ratio predicts overall survival of patients with localized and locally advanced clear cell renal cell carcinoma
[QIN Jiandi1,CHEN Zhen2,WANG Kai3,XU Xianlin3,PENG Xinqing1]
2023 04 [Abstract]()
[712-718] A comparison of different prophylactic intravesical chemotherapy regimens for bladder cancer recurrence after nephroureterectomy for upper tract urothelial carcinoma
[GAO Jianing,LI Hao,LIU Jingya,DING Dexin]
2023 04 [Abstract]()
[718-725] Clinical features,treatment and prognosis of eosinophilic granuloma of bone in children(33 cases)
[NIU Xueqiang,QU Yuran,WEN Long,LIU Yang]
2023 04 [Abstract]()
[725-732] Study on parameter selection of HT-TMI plan based on mucosal protection
[GAO Lu1,2,LI Xiaokai1,DIAO Yong1,JIANG Chaoyang1,DUAN Wenyue1,2,ZHANG Ling1,2]
2023 04 [Abstract]()
[733-736] Correlation between the cytokine levels before and after chemotherapy and involved chemotherapy-induced cognitive impairment in non-Hodgkin' s lymphoma patients
[LI Haowu,CHENG Huaidong,XUAN Han]
2023 04 [Abstract]()
[737-740] Clinical analysis of 18 cases of tumor lysis syndrome in childhood acute lymphoblastic leukemia
[DUN Jianxin,CUI Dongyan,ZHANG Ai,LIU Aiguo,HU Qun]
2023 04 [Abstract]()
[741-747] The value of SWI,3D-ASL and IVIM in the classification of glioma
[DU Changyue1,QI Xuhong2,WEN Zhiyong2,WANG Rengui1]
2023 04 [Abstract]()
[747-751] The value of dual time point 18F-FDG PET/CT in differentiating benign and malignant gastric lesions
[Adila·Adili,LI Xiaohong，QIN Yongde,Nazi·Yilihamu,ZHANG Lei]
2023 04 [Abstract]()
[752-755] Survival analysis of lung cancer patients in Shijiazhuang city
[DANG Jing,MA Xinyan,ZHAI Shiyong,GAO Cong,ZHANG Yulan]
2023 04 [Abstract]()
[759-763] Non-coding RNAs as remodelers of lipid metabolic reprogramming of malignant biological phenotype in hepatocellular carcinoma
[CHENG Jianze1,WANG Yumin2]
2023 04 [Abstract]()
[763-769] Research status and prospects of immune checkpoint inhibitors in the treatment of bladder cancer
[YANG Tianjun,PANG Lei,WEN Xiaodong]
2023 04 [Abstract]()
[770-774] Advances in risk factors and management strategies of checkpoint inhibitor pneumonitis
[WEN Yanping1,XIAO Haiwei2,SHEN Liping1,YIN Juhua1,LIU Lingshuang1]
2023 04 [Abstract]()
[774-778] Predictive biomarkers of immune checkpoint inhibitor
[LIU Meiqiu，GAO Quanli]
2023 04 [Abstract]()
[778-783] Research progress of the effects of microgravity on biological characteristics of tumor cells
[WANG Dapeng1,JIANG Xuege1,LIU Yuan2,WANG Junfeng1,LIU Changting1]
2023 04 [Abstract]()
[784-788] Progress of perioperative treatment for locally advanced gastric cancer
[CHEN Jiaxin，SUI Hong]
2023 04 [Abstract]()